Search

Your search keyword '"Tárraga, L."' showing total 184 results

Search Constraints

Start Over You searched for: Author "Tárraga, L." Remove constraint Author: "Tárraga, L."
184 results on '"Tárraga, L."'

Search Results

1. Evaluation of the Feasibility, Safety and Efficacy of the Use of Intravenous Infusions of Adenosine Triphosphate (ATP) in People Affected by Moderate to Severe Alzheimer’s Disease: A Double-Blind Masked Clinical Trial for Dose Finding

2. A novel Alzheimer disease locus located near the gene encoding tau protein.

3. Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project

5. Exploring APOE genotype effects on Alzheimer's disease risk and amyloid β burden in individuals with subjective cognitive decline: The FundacioACE Healthy Brain Initiative (FACEHBI) study baseline results

6. New insights into the genetic etiology of Alzheimer's disease and related dementias

9. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

10. Correlations between plasma and PET beta-amyloid levels in individuals with subjective cognitive decline: the Fundació ACE Healthy Brain Initiative (FACEHBI)

11. Cognitive plasticity in normal and pathological aging

12. New insights into the genetic etiology of Alzheimer's disease and related dementias

13. Genome-wide significant risk factors for Alzheimerʼs disease: role in progression to dementia due to Alzheimerʼs disease among subjects with mild cognitive impairment

14. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

16. ATP5H/KCTD2 locus is associated with Alzheimerʼs disease risk

17. 1st Conference Clinical Trials on Alzheimer’s Disease September 17-18-19, 2008 School of Medecine Montpellier, France

18. Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease

19. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

20. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

21. A novel Alzheimer disease locus located near the gene encoding tau protein

25. Plasma Aß42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study

26. Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease

27. Exploring APOE genotype effects on Alzheimer's disease risk and amyloid beta burden in individuals with subjective cognitive decline: The FundacioACE Healthy Brain Initiative (FACEHBI) study baseline results

28. Correction: Genetic risk for schizophrenia and psychosis in Alzheimer disease

29. Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease

30. PLASMA A?42/40 RATIO DETECTS EARLY STAGES OF ALZHEIMER’S DISEASE AND CORRELATES WITH CSF AND NEUROIMAGING BIOMARKERS IN THE AB255 STUDY

31. Genetic risk for schizophrenia and psychosis in Alzheimer disease

32. Follow-up of loci from the International Genomics of Alzheimer's Disease Project identifies TRIP4 as a novel susceptibility gene

33. Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia

34. Genome-wide significant risk factors for Alzheimer’s disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment

35. ATP5H/KCTD2 locus is associated with Alzheimer's disease risk

36. Follow-up of loci from the International Genomics of Alzheimer's Disease Project identifies TRIP4 as a novel susceptibility gene

37. The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer's disease

38. A two-year follow-up of cognitive deficits and brain perfusion in mild cognitive impairment and mild Alzheimer's disease.

40. Learning potential: a new method for assessing cognitive impairment.

41. Behavioral Pathology in Alzheimer's Disease Rating Scale (BEHAVE-AD): validación española.

42. Neuropsychiatric Inventory-Nursing Home version (NPI-NH): validación española.

45. Quantitative EEG biomarkers of cognitive performance in drug-resistant temporal lobe epilepsy.

46. Exploring sex differences in Alzheimer's disease: a comprehensive analysis of a large patient cohort from a memory unit.

47. Head-to-Head Comparison of Aptamer- and Antibody-Based Proteomic Platforms in Human Cerebrospinal Fluid Samples from a Real-World Memory Clinic Cohort.

48. Amyloid deposition in adults with drug-resistant temporal lobe epilepsy.

49. Head-to-head comparison of tau PET tracers [ 18 F]PI-2620 and [ 18 F]RO948 in non-demented individuals with brain amyloid deposition: the TAU-PET FACEHBI cohort.

50. Changes in choroidal thickness quantified by Optical Coherence Tomography across cognitive impairment: data from the NORFACE cohort.

Catalog

Books, media, physical & digital resources